What is the evidence for systemic effects of intravitreal anti-VEGF agents, and should we be concerned?. (10th December 2013)
- Record Type:
- Journal Article
- Title:
- What is the evidence for systemic effects of intravitreal anti-VEGF agents, and should we be concerned?. (10th December 2013)
- Main Title:
- What is the evidence for systemic effects of intravitreal anti-VEGF agents, and should we be concerned?
- Authors:
- Avery, Robert L
- Abstract:
- Abstract : Anti-vascular endothelial growth factor (VEGF) therapy has revolutionised the treatment of retinal disease, and appears to be very safe. Nevertheless, there are several lines of evidence that imply that small doses of these agents could potentially have a systemic effect. The clinical significance of these systemic effects remains unclear, but further study is indicated.
- Is Part Of:
- British journal of ophthalmology. Volume 98(2014)Supplement 1
- Journal:
- British journal of ophthalmology
- Issue:
- Volume 98(2014)Supplement 1
- Issue Display:
- Volume 98, Issue 1 (2014)
- Year:
- 2014
- Volume:
- 98
- Issue:
- 1
- Issue Sort Value:
- 2014-0098-0001-0000
- Page Start:
- i7
- Page End:
- i10
- Publication Date:
- 2013-12-10
- Subjects:
- Retina -- Pharmacology -- Drugs -- Macula -- Angiogenesis
Ophthalmology -- Periodicals
617.7 - Journal URLs:
- http://bjo.bmj.com/ ↗
http://bjo.bmjjournals.com/ ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/bjophthalmol-2013-303844 ↗
- Languages:
- English
- ISSNs:
- 0007-1161
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19579.xml